← Leaderboards
Edith Nakku-Joloba
New Mulago Hospital
$263,113
Attributed
$263,113
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $54K · FY2005–07$100K$75K$50K$25K$0
'05
'06
'07
Funding mix
By agency
NIH$263,113 · 1
By mechanism
R01$263,113 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Enzyme Linked Immunosorbent Assay”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,730,646
- Philip Louis Felgner · Gene Therapy Systems, Inc.$41,441,562
- Marianne Ward · Duke University$21,475,073
- Andrew B Norman · University Of Cincinnati$21,321,632
- Eric S. Orwoll · Oregon Health And Science University$20,906,524
- Andrew E. Levin · Immunetics, Inc.$20,730,152
Research focus
Enzyme Linked Immunosorbent AssayData Collection Methodology /EvaluationDisease /Disorder OnsetGenital HerpesSerology /SerodiagnosisQuestionnairesSex BehaviorDisease /Disorder Prevention /ControlAids /Hiv TestDisease /Disorder Proneness /RiskPublic HealthCommunicable Disease TransmissionAids TherapyLongitudinal Human StudyPatient Oriented ResearchHerpes Simplex Virus 2Hiv InfectionsGender DifferenceAfricaAge DifferenceHerpes Simplex Virus 1Clinical ResearchHuman SubjectUrban Poverty Area
Grant awards (5)
Seroprevallence and incidence of genital herpes in Uganda$49,813
R01 · FY2007 · TW · contact PI
Seroprevallence and incidence of genital herpes in Ugan*$51,300
R01 · FY2006 · TW · contact PI
Seroprevallence and incidence of genital herpes in Ugan*$54,000
R01 · FY2005 · TW
Seroprevallence and incidence of genital herpes in Ugan*$54,000
R01 · FY2004 · TW
Seroprevallence /incidence of genital herpes in Uganda$54,000
R01 · FY2003 · TW